Clinical trials
Completed Clostridium Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
128 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 6 |
| 2011 | 6 |
| 2012 | 10 |
| 2013 | 9 |
| 2014 | 7 |
| 2015 | 9 |
| 2016 | 12 |
| 2017 | 12 |
| 2018 | 9 |
| 2019 | 13 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 128 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Actelion | 4 |
| Mayo Clinic | 4 |
| Rebiotix Inc. | 4 |
| AstraZeneca | 3 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Sanofi Pasteur, a Sanofi Company | 3 |
| Seres Therapeutics, Inc. | 3 |
| Summit Therapeutics | 3 |
| University of Wisconsin, Madison | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Clostridium Infections | 128 |
| Diarrhea | 22 |
| Cross Infection | 6 |
| Enterocolitis, Pseudomembranous | 6 |
| Bacterial Infections | 3 |
| Communicable Diseases | 3 |
| Diabetes Insipidus, Neurogenic | 3 |
| Gastrointestinal Diseases | 3 |
| Inflammatory Bowel Diseases | 3 |
| Pneumonia | 3 |
Trials
Showing 51 to 75 of 128. Each trial links to its page on Pharma Observatory.
28 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.